Lotus Bio-Technology Development Corp. operating under the name Focal Point Healthcare, is an At-home, digital health testing corporation supporting women's health, men's health, dietary health and sexual health. The Company delivers a series of at-home diagnostic tests that help form a complete picture of their current overall health including hormone levels, allergies, sensitivities, and any pre-existing conditions or infections. Then, based on those results, and a user's interests, lifestyle and goals, an advisor from The Company works with the individual one on one to help customize a wellness plan that incentivizes them to continue caring for their health and reach new goals. Through the Company's at-home diagnostic testing, customizable wellness plans, and strategic partnerships, the Company provides access to healthcare and improve quality of life for its users.

Employees

Sector

Healthcare Facilities & Services

More about the company

23-02-15	Lotus Bio-Technology Development Corp. acquired Pioneer Digital Health, Inc.	CI
22-12-22	Lotus Bio-Technology Development Corp. announced that it has received $0.05 million in funding	CI

Market Cap	662K 580K 537K 493K 931K 63.86M 946K 6.42M 2.51M 31.24M 2.49M 2.43M 108M	P/E 2016	-58.1x	P/E 2017	-593x
Enterprise Value	731K 641K 593K 545K 1.03M 70.53M 1.04M 7.09M 2.78M 34.51M 2.75M 2.69M 119M	EV / Sales 2016	-	EV / Sales 2017	-
Free-Float	4.07%	Yield 2016 *	-	Yield 2017	-

23-02-15	Lotus Bio-Technology Development Corp. acquired Pioneer Digital Health, Inc.	CI
22-12-22	Lotus Bio-Technology Development Corp. announced that it has received $0.05 million in funding	CI
22-12-13	Lotus Bio-Technology Development Corp. announced that it expects to receive $0.05 million in funding	CI
22-10-24	BioGnomics Lab, LLC acquired Boomerangkit.com, LLC from Lotus Bio-Technology Development Corp..	CI
22-08-16	Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Zoltan Nagy as Director	CI
22-07-06	Lotus Bio-Technology Development Corp. Appoints Hoyt Christopher as CEO	CI
22-07-05	Lotus Bio-Technology Development Corp. acquired Boomerangkit.com, LLC/Focal Point, Inc. from Focal Point, Inc. and Boomerangkit.com, LLC.	CI
22-04-12	Lotus Bio-Technology Development Corp. entered into a binding letter of intent to acquire Little Jupiter Gold Project in Nevada, USA from AMT Industries Canada Inc.	CI
21-04-07	Lotus Bio-Technology Development Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2017	CI
21-01-27	Lotus Bio-Technology Development Corp. Reports Earnings Results for the First Quarter Ended June 30, 2017	CI
19-04-10	Lotus Bio-Technology Development Corp. Announces Executive Changes	CI
18-12-21	Lotus Bio-Technology Development Corp. cancelled the acquisition of Coin Rig Solution.	CI
17-12-21	Lotus Bio-Technology Development Corp. entered into significant agreement with Coin Rig Solution.	CI

23-02-16	Lotus Bio-Technology Development Corp. Increases Their Footprint in the Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Pioneer Digital Health	AQ
22-10-25	Lotus Bio-Technology Development Corp. announces sale of Boomerangkit.com, LLC	PR
22-08-29	Lotus Bio-Technology Development Corp. Releases Shareholder Update Addressing Securities and Exchange Commission's Complaint	PR
22-08-19	Lotus Bio Technology Development : Current Report	PU
22-08-16	Lotus Bio-Technology Development Corp, Inc. Initiates Company Name Change	PR

Director	Title	Age	Since
Michael Jay Solomon BRD	Director/Board Member	87	2022-09-30
William McDonald BRD	Director/Board Member	-	2022-10-23
William Graves BRD	Director/Board Member	-	-

Starflick.com Stock OTC Bulletin Board

Stocks

US85529D2036

Healthcare Facilities & Services

Valuation: Starflick.com

Latest news : Starflick.com

Press Releases: Starflick.com

Managers and Directors: Starflick.com

Other Healthcare Facilities & Services

Financials

Company Profile

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CVS HEALTH CORPORATION	+0.13%	+1.61%	+73.68%	+43.73%	137B
HCA HEALTHCARE, INC.	-0.20%	-5.20%	+2.58%	+29.11%	82.17B
FRESENIUS SE & CO. KGAA	+0.66%	+5.58%	+6.26%	+52.13%	27.63B
QUEST DIAGNOSTICS INCORPORATED	-1.43%	+0.15%	+24.41%	+44.61%	22.99B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.56%	-0.05%	-15.84%	-28.82%	20.07B
TENET HEALTHCARE CORPORATION	-0.27%	-0.22%	+11.04%	+146.30%	16.74B
REDE D'OR SÃO LUIZ S.A.	-0.92%	-0.31%	+7.78%	+6.26%	15.32B
DAVITA INC.	-1.21%	-0.63%	+65.84%	+121.92%	15.03B
FRESENIUS MEDICAL CARE AG	+1.28%	+0.78%	-5.53%	-12.55%	12.81B
Average	-0.28%	-0.33%	+18.91%	+44.74%	38.9B
Weighted average by Cap.	-0.13%	-0.44%	+34.18%	+41.42%

	2016	2017
Net sales	-	-
Net income	-781K -685K -633K -582K -1.1M -75.32M -1.12M -7.57M -2.97M -36.85M -2.93M -2.87M -127M	-19.55K -17.14K -15.84K -14.57K -27.49K -1.89M -27.93K -189K -74.24K -922K -73.41K -71.81K -3.18M
Net Debt	-5 -4.38 -4.05 -3.73 -7.03 -482.16 -7.14 -48.44 -18.99 -235.91 -18.78 -18.37 -812.79	69.21K 60.66K 56.07K 51.57K 97.3K 6.67M 98.86K 670K 263K 3.27M 260K 254K 11.25M